|
[Related PubMed/MEDLINE]
Total Number of Papers: 183
|
|
|
| |
|
[Display Entries]
|
|
>> all entries
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2022 |
A multi-center, international, randomized, 2-year, parallel-group study to assess the superiority of IVUS-guided PCI versus qualitative angio-guided PCI in unprotected left main coronary artery (ULMCA) disease: Study protocol for OPTIMAL trial. |
ARC, IVUS, LMCA, PCI, POCE |
| 2 |
2022 |
Percutaneous coronary intervention in unprotected left main coronary artery stenosis: Mid-term outcomes of a single-center observational study. |
CABG, DES, MACCE, PCI |
| 3 |
2021 |
Clinical Outcomes of Dialysis Patients Treated with Drug-Eluting Stent for Left Main Distal Bifurcation Lesions. |
DES, HD, HR, PCI, TLF, TLR |
| 4 |
2021 |
Long-term (≥15 years) Follow-up of Percutaneous Coronary Intervention of Unprotected Left Main (From the GRAVITY Registry). |
CV, PCI |
| 5 |
2021 |
Percutaneous coronary intervention versus coronary artery surgery for left main disease according to lesion site: A meta-analysis. |
CABG, CI, HR, MACE, PCI, RCTs |
| 6 |
2021 |
Percutaneous Coronary Intervention Vs Coronary Artery Bypass Surgery for Unprotected Left Main Coronary Disease: G-LM Registry. |
CABG, EuroSCORE, MACCE |
| 7 |
2021 |
Percutaneous Treatment of Unprotected Left Main Disease With Thin-Strut Durable-Polymer or Early Generation Thicker-Strutted and Coated Bioabsorbable-Polymer Drug-Eluting Stents in a Large-Scale Registry. |
DES, PCI, TLF |
| 8 |
2021 |
Short- and Long-Term Prognosis of Intravascular Ultrasound-Versus Angiography-Guided Percutaneous Coronary Intervention: A Meta-Analysis Involving 24,783 Patients. |
IVUS, MI, PCI, RCTs, ST, TLR, TVR |
| 9 |
2021 |
The Utility of Peripheral Intravascular Lithotripsy in Calcific Coronary Artery Disease: A Case Series. |
CAC, IVL, MACE |
| 10 |
2021 |
[Long-term outcomes and risk factors of ostial/shaft lesions in unprotected left main coronary artery after percutaneous coronary intervention]. |
DES, LVEF, MI, PCI |
| 11 |
2020 |
Impact of Elective, Uncomplicated Target Lesion Revascularization on Cardiac Mortality After Elective Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Disease. |
CI, HZ, MI, PCI, TLR |
| 12 |
2020 |
Left ventricular systolic dysfunction in patients with unprotected left main coronary artery disease. |
CABG, DES, LVSD, PCI |
| 13 |
2020 |
Long-term outcomes of percutaneous coronary intervention for unprotected left main coronary artery according to the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) score. |
CABG, CI, MACE, MI, PCI, SYNTAX, TVR |
| 14 |
2020 |
Long-term outcomes of single stenting compared with double stenting strategy for unprotected left main coronary artery disease: A protocol for systematic review and meta-analysis. |
--- |
| 15 |
2020 |
Long-Term Outcomes of Unprotected Left Main Coronary Artery Disease: Comparison of Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention. |
CABG, MACCE, MI, PCI, PSM, TVR |
| 16 |
2020 |
Long-Term Prognostic Impact of Restenosis of the Unprotected Left Main Coronary Artery Requiring Repeat Revascularization. |
CI, HR, TLR |
| 17 |
2020 |
Percutaneous Coronary Intervention for Left Main Coronary Artery Bifurcation Lesions: Two-stent versus one-stent Strategy for Comparison of 6-month MACE. |
CABG, DS, KB, MACE, PCI, ss, TLR |
| 18 |
2020 |
Twelve-year outcomes after revascularization for ostial/shaft lesions in unprotected left main coronary artery. |
CABG, DES, MI, PCI |
| 19 |
2020 |
[Long-term outcome comparison of ostial/shaft lesions in unprotected left main coronary artery treated by PCI or CABG]. |
CABG, DES, MI, PCI |
| 20 |
2019 |
Intravascular ultrasound-guided drug-eluting stent implantation for patients with unprotected left main coronary artery lesions: A single-center randomized trial. |
DES, IVUS, MACEs, MI, ST, TVR |
| 21 |
2019 |
Long-term outcome in patients treated with first- versus second-generation drug-eluting stents for the treatment of unprotected left main coronary artery stenosis. |
CI, DES, HR, PCI |
| 22 |
2019 |
Nonemergent Percutaneous Coronary Intervention on an Unprotected Left Main Coronary Artery Supported with Impella® Heart Pump in Patients Ineligible for Surgical Revascularization. |
CABG, MACCE, PCI |
| 23 |
2019 |
Predictors of survival in patients with acute coronary syndrome undergoing percutaneous coronary intervention of unprotected left main coronary artery stenosis. |
CABG, PCI |
| 24 |
2019 |
Prospective evaluation of drug eluting self-apposing stent for the treatment of unprotected left main coronary artery disease: 1-year results of the TRUNC study. |
TLF |
| 25 |
2018 |
Long term outcomes of drug-eluting stent versus coronary artery bypass grafting for left main coronary artery disease: a meta-analysis. |
CABG, DES, MI |
| 26 |
2018 |
Long-Term Outcomes of Different Two-Stent Techniques With Second-Generation Drug-Eluting Stents for Unprotected Left Main Bifurcation Disease: Insights From the FAILS-2 Study. |
MI, ST, TLR |
| 27 |
2018 |
One-year Outcomes in Patients with ST-segment Elevation Myocardial Infarction Caused by Unprotected Left Main Coronary Artery Occlusion Treated by Primary Percutaneous Coronary Intervention. |
MACEs, NSTEMI, PCI, STEMI, TIMI |
| 28 |
2018 |
Orbital Atherectomy of Severely Calcified Unprotected Left Main Coronary Artery Disease: One-Year Outcomes. |
MACCE, PCI |
| 29 |
2018 |
Outcome and selection of revascularization strategy in left main coronary artery stenosis. |
MACCE |
| 30 |
2018 |
Sex difference among patients with unprotected left main coronary artery disease undergoing percutaneous coronary intervention in northern China. |
CAG, PCI |
| 31 |
2018 |
Unprotected Left Main Coronary Artery Disease: Management in the Post NOBLE and EXCEL Era. |
CABG, PCI |
| 32 |
2018 |
Unprotected Left Main Coronary Artery Disease: Outcomes of Treatment With Second-Generation Drug-Eluting Stents - Insight From the FAILS-2 Study. |
BP-BES, DES, EES, MI, ST, TLR, ZES |
| 33 |
2017 |
CABG Surgery Remains the best Option for Patients with Left Main Coronary Disease in Comparison with PCI-DES: Meta-Analysis of Randomized Controlled Trials. |
CABG, DES, PCI, RR, TVR |
| 34 |
2017 |
Comparative determinants of 5-year cardiovascular event rates in patients with unprotected left main coronary artery disease. |
CAD, CI, DM, EF, HR, MACCE |
| 35 |
2017 |
Impella 2.5 initiated prior to unprotected left main PCI in acute myocardial infarction complicated by cardiogenic shock improves early survival. |
AMICS, PCI, pLVAD |
| 36 |
2017 |
Left main coronary stenosis: surgery still reigns. |
CABG, PCI, RCTs |
| 37 |
2017 |
Meta-Analysis of Comparison of 5-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Unprotected Left Main Coronary Artery in the Era of Drug-eluting Stents. |
CABG, CI, DES, OR, PCI |
| 38 |
2017 |
Meta-Analysis of Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main CoronaryNarrowing. |
CABG, DES, MI, ORs, PCI, RCTs |
| 39 |
2017 |
Meta-Analysis of Randomized Control Trials Comparing Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Significant Left Main Coronary Narrowing. |
CABG, CI, DES, MACCE, RCTs, RR |
| 40 |
2017 |
Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study. |
MACEs, PCI, PS, TLR |
| 41 |
2017 |
Reduced duration of dual antiplatelet therapy using an improved drug-eluting stent for percutaneous coronary intervention of the left main artery in a real-world, all-comer population: Rationale and study design of the prospective randomized multicenter IDEAL-LM trial. |
DAPT, PCI |
| 42 |
2017 |
[Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery]. |
CABG, DES, HR, MI, PCI, PSM |
| 43 |
2016 |
Acute myocardial infarction due to left main coronary artery disease in men and women: does ST-segment elevation matter? |
NSTEMI, PCI, STEMI |
| 44 |
2016 |
Angioplasty of unprotected left main coronary stenosis: Real world experience of a single-operator group from eastern India. |
LVEF, MACE |
| 45 |
2016 |
Computing Methods for Composite ClinicalEndpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry. |
CABG, PCI, TTE, WCE, WR |
| 46 |
2016 |
Impact of chronic kidney disease on patients with unprotected left main coronary artery disease treated with coronary artery bypass grafting or drug-eluting stents. |
CABG, CI, DESs, eGFRs, MI |
| 47 |
2016 |
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. |
ACS, CABG, DELTA, DES, MI, PCI |
| 48 |
2016 |
Long-term prognosis of patients with acute myocardial infarction due to unprotected left main coronary artery disease: a single-centre experience over 14 years. |
AMI, CS, OR, TIMI |
| 49 |
2016 |
Percutaneous Coronary Intervention in Severely Calcified Unprotected Left Main Coronary Artery Disease: Initial Experience With Orbital Atherectomy. |
PCI |
| 50 |
2016 |
Two-year clinical outcomes in stable angina and acute coronary syndrome after percutaneous coronary intervention of left main coronary artery disease. |
ACS, MACE, PCI, SAP |
| 51 |
2016 |
Very Long-term Outcomes and Predictors of Percutaneous Coronary Intervention with Drug-eluting Stents Versus Coronary Artery Bypass Grafting for Patients with Unprotected Left Main Coronary Artery Disease. |
CABG, DES, EF, MI, PCI |
| 52 |
2015 |
Clinical comparison of percutaneous coronary intervention with domestic drug-eluting stents versus off pump coronary artery bypass grafting in unprotected left main coronary artery disease. |
CABG, DES, MACCE, MI, PCI, TVR |
| 53 |
2015 |
Clinical Outcomes After Percutaneous Coronary Intervention in Acute Myocardial Infarction Due to Unprotected Left Main Coronary Artery Disease. |
AMI, PCI |
| 54 |
2015 |
Clinical outcomes of "complete, partially complete, and incomplete" revascularisation at five-year follow-up after percutaneous intervention of unprotected left main coronary artery disease with drug-eluting stents. |
CI, DES, HR, ICR, MACE, PCI, PCR |
| 55 |
2015 |
Influence of diabetes mellitus on long-term outcomes of patients with unprotected left main coronary artery disease treated with either drug-eluting stents or coronary artery bypass grafting. |
CABG, DES, PCI |
| 56 |
2015 |
Intravascular ultrasound-guided unprotected left main coronary artery stenting in the elderly. |
CI, HR, IVUS, MACE, PCI |
| 57 |
2015 |
Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II. |
CABG, OR, PCI, PIs |
| 58 |
2015 |
One-stent versus two-stent techniques for distal unprotected left main coronary artery bifurcation lesions. |
PCI |
| 59 |
2015 |
The EXCEL and NOBLE trials: similarities, contrasts and future perspectives for left main revascularisation. |
CABG, DES, PCI |
| 60 |
2015 |
The STENTYS paclitaxel-eluting stent in the treatment of unprotected distal left main. |
DES, IVUS |
| 61 |
2015 |
Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials. |
DES, MI, PCI |
| 62 |
2015 |
[Long-term outcomes of patients with unprotected left main coronary artery disease post revascularization]. |
CABG, DES, MI, PCI |
| 63 |
2014 |
Acute changes of left ventricular hemodynamics and function during percutaneous coronary intervention in patients with unprotected left main coronary artery disease. |
EDP, GLS, LV, PCIs |
| 64 |
2014 |
Calcification analysis by intravascular ultrasound to define a predictor of left circumflex narrowing after cross-over stenting for unprotected left main bifurcation lesions. |
IVUS, LAD, LCX, PSN-LCx |
| 65 |
2014 |
Clinical outcomes of transradial unprotected left main coronary artery stenting in the elderly. |
MACE, PCI |
| 66 |
2014 |
Comparison of one-year clinical outcomes between intravascular ultrasound-guided versus angiography-guided implantation of drug-eluting stents for left main lesions: a single-center analysis of a 1,016-patient cohort. |
IVUS |
| 67 |
2014 |
Comparison of percutaneous coronary intervention (with drug-eluting stents) versus coronary artery bypass grafting in women with severe narrowing of the left main coronary artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry). |
CABG, CI, CVA, MI, OR, PCI |
| 68 |
2014 |
Drug-eluting stents in unprotected left main coronary artery disease. |
CABG, DES |
| 69 |
2014 |
First generation versus new generation drug-eluting stents for the treatment of ostial/midshaft lesions in unprotected left main coronary artery: the Milan and New-Tokyo (MITO) registry. |
CI, DES, HR, MACE, MITO, PCI |
| 70 |
2014 |
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. |
CABG, CI, DES, HR, HR, MI, PCI |
| 71 |
2014 |
Long-term outcomes of percutaneous coronary interventions or coronary artery bypass grafting for left main coronary artery disease in octogenarians (from a Drug-Eluting stent for LefT main Artery registry substudy). |
CABG, PCI |
| 72 |
2014 |
Mortality in cardiogenic shock complicating acute myocardial infarction due to left main coronary artery disease: does gender matter? |
CS, MI, PL-ACS |
| 73 |
2014 |
Percutaneous coronary intervention for acute myocardial infarction due to unprotected left main coronary artery occlusion: status update 2014. |
AMI, CABG, NSTEMI, PCI, STEMI, TIMI |
| 74 |
2014 |
Readmission rate after coronary artery bypass grafting versus percutaneous coronary intervention for unprotected left main coronary artery narrowing. |
CABG, PCI |
| 75 |
2014 |
Safety and feasibility of coronary stenting in unprotected left main coronary artery disease in the real world clinical practice--a single center experience. |
AKI, BMI, CHF, ECMO, NSTEMI, WBC |
| 76 |
2014 |
Single versus double stenting for unprotected left main coronary artery bifurcation lesions: a systematic review and meta-analysis. |
CI, DES, DS, MACE, OR, PCI, ss, TLR/TVR |
| 77 |
2014 |
Unprotected left main coronary artery percutaneous coronary intervention in a pediatric patient with cardiac allograft vasculopathy. |
CAV, OHT, PCI |
| 78 |
2013 |
A systematic review and meta-analysis on primary percutaneous coronary intervention of an unprotected left main coronary artery culprit lesion in the setting of acute myocardial infarction. |
AMI, CI, PCI |
| 79 |
2013 |
Acute myocardial infarction due to left main coronary artery disease: a large multicenter national registry. |
MI, PCI, STEMI |
| 80 |
2013 |
Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. |
CABG, COPD, LVEF, PCI |
| 81 |
2013 |
Clinical outcomes after percutaneous or surgical revascularisation of unprotected left main coronary artery-related acute myocardial infarction: a single-centre experience. |
AMI, CABG, PCI, TIMI |
| 82 |
2013 |
Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry. |
SES, TLR |
| 83 |
2013 |
Comparison of sirolimus-, paclitaxel-, and everolimus-eluting stent in unprotected left main coronary artery percutaneous coronary intervention. |
DES, EES, PCI, PES, SES |
| 84 |
2013 |
Coronary artery bypass graft versus percutaneous coronary intervention with drug-eluting stent implantation for diabetic patients with unprotected left main coronary artery disease: the D-DELTA registry. |
CVA |
| 85 |
2013 |
Everolimus- versus sirolimus-eluting stents for the treatment of unprotected left main coronary artery stenosis (results from the EXCELLENT registry). |
MACE, SES |
| 86 |
2013 |
Five-year outcomes following PCI with DES versus CABG for unprotected LM coronary lesions: meta-analysis and meta-regression of 2914 patients. |
CABG, DES, MACCE, OR, PCI, TVR |
| 87 |
2013 |
Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease. |
DES, ISR, PCI, TBL, TLR |
| 88 |
2013 |
Is percutaneous coronary intervention of unprotected left main coronary artery via transradial approach feasible for skilled transfemoral operators? Initial experience in an unselected population. |
MACE, PCI, TFA, TRA |
| 89 |
2013 |
Long term clinical outcomes in DES implantation for unprotected left main disease. |
DES, PCI, PES, ST, TLR, TVR |
| 90 |
2013 |
Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. |
CI, DES, HR, PCI |
| 91 |
2013 |
New-generation drug-eluting stent experience in the percutaneous treatment of unprotected left main coronary artery disease: the NEST registry. |
DES, MACEs, MI, PCI, ST, TVR |
| 92 |
2013 |
Outcome of percutaneous coronary intervention with drug-eluting stents in unprotected left main versus non-left main native coronary artery disease: results from the prospective multicenter German DES.DE registry. |
DES, MACCE, MI, nLMCA, PCI, TVR |
| 93 |
2013 |
Outcomes of coronary artery interventions: comparing coronary artery bypass surgery and percutaneous coronary intervention in patients with unprotected left main stenosis. |
CABG, PCI |
| 94 |
2013 |
Percutaneous coronary intervention of unprotected left main disease: five-year outcome of a single-center registry. |
MACE, MI, PCI, TLR |
| 95 |
2013 |
Unprotected left main coronary artery disease. Surgical therapy. |
CABG |
| 96 |
2013 |
Unprotected left main PCI: status report 2013. |
PCI |
| 97 |
2013 |
Zotarolimus- versus everolimus-eluting stents for unprotected left main coronary artery disease. |
CI, EES, ZES |
| 98 |
2012 |
A comparison between coronary artery bypass grafting surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease. |
CABG, DESs, EuroSCORE, PCI, SYNTAX |
| 99 |
2012 |
Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008. |
CI, HRs, IPW, PCI |
| 100 |
2012 |
Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in patients undergoing unprotected left main coronary artery stenting. |
MACE |
|
A Search Service for Abbreviation / Long Form
